GlyCardial Diagnostics has been granted with regional and sectorial Emprendedor XXI prize.

GlyCardial Diagnostics has been granted with regional and sectorial Emprendedor XXI prize.

In this edition, six sectors linked to new trends in innovation and CaixaBank business areas have been defined: Agro Tech, Health Tech, Commerce Tech, Fin&InsurTech, Tourism Tech and Impact Tech.

GlyCardial Diagnostics has been recognized as the most innovative company in the Health Tech category, both in regional and sectorial sections.

In addition to the economic prize, winners will also have access to international training and will be able to enjoy an international accompaniment programme in Silicon Valley, organised by ESADE in collaboration with Singularity University.